VSee Health, Inc. (NASDAQ:VSEE) Sees Large Growth in Short Interest

VSee Health, Inc. (NASDAQ:VSEEGet Free Report) was the target of a significant growth in short interest in July. As of July 31st, there was short interest totaling 7,318,494 shares, a growth of 344.2% from the July 15th total of 1,647,591 shares. Based on an average daily trading volume, of 21,913,840 shares, the days-to-cover ratio is presently 0.3 days. Currently, 203.3% of the company’s stock are sold short.

Institutional Trading of VSee Health

A hedge fund recently bought a new stake in VSee Health stock. Virtu Financial LLC acquired a new position in VSee Health, Inc. (NASDAQ:VSEEFree Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 66,489 shares of the company’s stock, valued at approximately $25,000. 1.01% of the stock is owned by institutional investors and hedge funds.

VSee Health Trading Up 47.4%

Shares of VSEE stock opened at $0.04 on Wednesday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 0.41 and a current ratio of 0.41. The company has a market capitalization of $133,200.00 and a price-to-earnings ratio of -0.07. VSee Health has a 52-week low of $0.01 and a 52-week high of $2.52. The company has a 50-day simple moving average of $0.10 and a two-hundred day simple moving average of $0.21.

VSee Health (NASDAQ:VSEEGet Free Report) last posted its earnings results on Friday, May 15th. The company reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.11) by $0.06. VSee Health had a negative net margin of 92.36% and a negative return on equity of 11,636.34%. The firm had revenue of $3.16 million for the quarter, compared to analysts’ expectations of $4.80 million.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of VSee Health in a research note on Friday, July 17th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, VSee Health has a consensus rating of “Sell”.

View Our Latest Stock Report on VSee Health

About VSee Health

(Get Free Report)

VSee Health is a telehealth technology company that develops secure, HIPAA-compliant software solutions for virtual care. The company’s flagship platform offers high-definition video visits, real-time messaging and collaboration tools designed to streamline remote consultations between patients and healthcare providers. VSee’s solutions are built to integrate with electronic health record systems and include features such as digital waiting rooms, screen sharing and file transfer capabilities.

In addition to video conferencing, VSee Health provides remote patient monitoring (RPM) tools that enable clinicians to collect biometric data, such as blood pressure, heart rate and glucose readings, from patients in their homes.

See Also

Receive News & Ratings for VSee Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VSee Health and related companies with MarketBeat.com's FREE daily email newsletter.